Challenges of 2020: Lessons for Clinical Trials in Diabetes

November 23, 2020

The extraordinary challenges of 2020—the global pandemic and the renewed campaign against racial injustice—have simultaneously presented opportunities for significant growth and change across the clinical research industry.

Previous Article
Third Time’s the Charm – FDA Publishes Final Guidance on Insanitary Conditions
Third Time’s the Charm – FDA Publishes Final Guidance on Insanitary Conditions

In the Federal Register notice, FDA reiterated that drug products compounded under insanitary conditions co...

Next Article
Fostering steady advances in data operations: FSP partnerships can spur and support change
Fostering steady advances in data operations: FSP partnerships can spur and support change

When we discuss innovation in clinical trials, it’s easy to think first of technologies involving digital h...